8 completed, 1 terminated. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 7, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow antroquinonol: new trials by email Literature Review of antroquinonol trials Research Report on antroquinonol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients Antroquinonol, Placebo - Covid-19 | Phase 2 | Completed | Golden Biotechnology Corporation | 124 | 2020-10-15 | 2023-12-13 |
| Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients Antroquinonol - Leukemia, Myeloid, Acute | Phase 2 | Completed | Golden Biotechnology Corporation | 12 | 2019-02-20 | 2021-02-03 |
| A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis Antroquinonol Capsule 50mg, Antroquinonol Capsule 100mg, Placebo oral capsule - Atopic Dermatitis | Phase 2 | Terminated | Chung Shan Medical University | 14 | 2018-07-27 | 2019-10-01 |
| A Trial of Antroquinonol in Patients With Atopic Dermatitis Antroquinonol, Placebo - Atopic Dermatitis | Phase 2 | Completed | Golden Biotechnology Corporation | 14 | 2018-07-17 | 2019-08-29 |
| A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B Antroquinonol, placebo - HBV | Phase 2 | Completed | Golden Biotechnology Corporation | 60 | 2018-02-12 | 2026-10-19 |
| Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer Antroquinonol - Pancreatic Neoplasm | Phase 1 / Phase 2 | Completed | Golden Biotechnology Corporation | 55 | 2017-12-01 | 2026-07-02 |
| Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia Antroquinonol, placebo - Hyperlipidemias | Phase 2 | Completed | Golden Biotechnology Corporation | 120 | 2016-05-01 | 2020-01-02 |
| Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC Antroquinonol - Non-small Cell Lung Cancer Stage IV | Phase 2 | Completed | Golden Biotechnology Corporation | 31 | 2013-10-01 | 2019-12-26 |
| Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects Antroquinonol - Non-small Cell Lung Cancer | Phase 1 | Completed | Golden Biotechnology Corporation | 13 | 2010-12-01 | 2016-06-21 |
Carcinoma, Non-Small-Cell Lung (2) · Dermatitis, Atopic (2) · COVID-19 (1) · Hyperlipidemias (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1) · Pneumonia (1)
Golden Biotechnology Corporation (8) · Chung Shan Medical University (1)
Taiwan (7) · United States (3) · Argentina (1) · Peru (1) · Russia (1) · South Korea (1)
Cheng-Chung Wei, MD (2) · Ching-Pin Lin, MD (1) · Fu-Tien Chiang, M.D. (1) · Howard Cheng, Ph.D. (1) · Wei C- C, M.D. (1) · Woei-Yau Kao, M.D. (1) · Yu-Chin Lee, M.D. (1)